Cognition Therapeutics, Inc. (CGTX)

Cognition Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.76	36.81	25.01	29.92	41.56	54.72
Cash & Short-Term Investments	30.76	36.81	25.01	29.92	41.56	54.72
Cash Growth	-21.80%	47.19%	-16.42%	-28.01%	-24.05%	954.56%
Other Receivables	2.5	9.92	2.69	1.28	3.67	2.27
Receivables	2.5	9.92	2.69	1.28	3.67	2.27
Prepaid Expenses	0.26	1.07	1.86	3.02	2.41	2.01
Restricted Cash	0.72	0.19	-	-	-	-
Total Current Assets	34.24	47.99	29.56	34.22	47.65	58.99
Property, Plant & Equipment	0.56	0.4	0.68	0.94	1.05	0.15
Other Long-Term Assets	-	-	-	-	1.73	-
Total Assets	34.8	48.39	30.23	35.16	50.43	59.14

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.45	1.12	1.98	3.7	3.22	4.17
Accrued Expenses	3.88	12	7.62	4.05	2.09	1.75
Short-Term Debt	-	0.31	0.28	0.54	0.63	-
Current Portion of Leases	0.09	0.14	0.19	0.17	0.15	-
Current Unearned Revenue	0.72	0.37	1.07	1.7	1.7	0.75
Other Current Liabilities	-	-	-	-	-	1.19
Total Current Liabilities	5.13	13.92	11.14	10.17	7.8	7.86
Long-Term Leases	0.4	0.2	0.34	0.52	0.7	-
Long-Term Unearned Revenue	-	-	-	-	1.69	-
Total Liabilities	5.53	14.12	11.48	10.69	10.18	7.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.1	0.09	0.06	0.03	0.03	0.02
Additional Paid-In Capital	240.48	232.83	193.85	165.83	155.82	145.45
Retained Earnings	-211.29	-198.65	-175.16	-141.19	-115.4	-94
Comprehensive Income & Other	-	-	-	-0.2	-0.2	-0.2
Total Common Equity	29.28	34.27	18.75	24.47	40.25	51.27
Shareholders' Equity	29.28	34.27	18.75	24.47	40.25	51.27
Total Liabilities & Equity	34.8	48.39	30.23	35.16	50.43	59.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.49	0.64	0.81	1.24	1.48	-
Net Cash (Debt)	30.27	36.17	24.2	28.68	40.08	54.72
Net Cash Growth	-22.30%	49.50%	-15.65%	-28.44%	-26.75%	-
Net Cash Per Share	0.33	0.50	0.61	0.96	1.70	10.54
Filing Date Shares Outstanding	95.1	89.35	61.97	39	29.26	22.58
Total Common Shares Outstanding	95.1	88.9	59.85	32.17	28.99	22.23
Working Capital	29.11	34.07	18.41	24.05	39.85	51.13
Book Value Per Share	0.31	0.39	0.31	0.76	1.39	2.31
Tangible Book Value	29.28	34.27	18.75	24.47	40.25	51.27
Tangible Book Value Per Share	0.31	0.39	0.31	0.76	1.39	2.31
Machinery	-	0.28	1.34	1.33	1.19	1.02

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error